Bronchiolitis is arguably the most common
|
|
- Ariel O’Neal’
- 6 years ago
- Views:
Transcription
1 MANAGEMENT OF BRONCHÍOLITIS Focus ON HYPERTONIC SALINE BRIAN ALVERSON, MD, AND SHAWN LEIGH RALSTON, MD There is a lack of effective treatment options for bronchiolitis, the most common viral respiratory tract infection in children and infants. Emerging evidence suggests that nebulized hypertonic saline may have some value. Bronchiolitis is arguably the most common significant medical illness of childhood. At least 1 in 7 normal infants will develop symptomatic bronchiolitis in his or her first year of life.' Hospitalization of infants for bronchiolitis is responsible for an annual expenditure of more than a half billion dollars.^ Despite the extraordinary prevalence of this condition, the disease confers very little mortality. There are about 100 deaths resulting from bronchiolitis each year, and the bulk of these deaths are in children with other underlying conditions such as chronic lung disease, congenital heart disease, or other chronic diseases.''' Pathophysiology Respiratory syncytial virus (RSV) infection remains the most common cause of bronchiolitis, but recently, multiple other viruses, including adenovirus, parainfluenza virus, influenza, coronavirus, rhinovirus, and human metapneumovirus, have been recognized as etiologic agents of the condition.^"^ The growing list of causative pathogens for bronchiolitis is not so much a reflection of rapid viral evolution as it is a result of our better understanding of the viral pool. Human metapneumovirus first gained recognition as a major pathogen in bronchiolitis in 2004.' Previously considered the least pathogenic of viruses, rhinovirus has been implicated as an organism in particularly severe disease.' There doubtlessly will be more viruses discovered in the near future. Severity of illness in infants is related not only to the identity of the virus but also to the viral burden in the respiratory tract and perhaps also coinfection with multiple viruses.*' Coinfection is much more common than initially suspected, especially in ill patients. In 1 study, children infected with RSV and coinfection with another virus were more likely to have fever and leukocytosis and more likely to receive antibiotics than if they had RSV infection alone, although this was not necessarily true for other viruses.* Other studies have reported higher rates of pneumonia or gastrointestinal symptoms, increased hospital stay, and/or increased need for oxygen associated with coinfection.'""'-' All the studies, however, have some design limitations, so whether increased severity or other detrimental outcomes result from coinfection still requires further confirmation. In both inpatient and community settings, contact and droplet precautions should be the mainstay of prevention of viral transmission. V is director. Division of Pédiatrie Hospital Medicine, Hasbro Children's Hospital, Providence, Rhode Island, and assistant professor of pediatrics, Brown University, Providence. "'' ii'-l : is associate professor of pediatrics, University of Texas Health Science Center, San Antonio, Texas. The authors have nothing to disclose regarding affiliation with, or financial interests in, any organization that may have an interest in any part of this article. l 30 CONTEMPORARY PEDIATRICS FEBRUARY 2011
2 Making the diagnosis Many practitioners rely on various tests to distinguish between viral and bacterial disease in infants with symptoms of bronchiolitis. However, questions have emerged regarding the usefulness of routine testing in this illness. It usually is not necessary for clinicians to identify the exact pathogen(s) responsible for an individual case of bronchiolitis. The American Academy of Pediatrics (AAP) has recommended against routine viral testing because it rarely changes the management of the disease (which usually is symptomatic) and can be quite expensive.'^ Similarly, the AAP has recommended against any other routine laboratory or radiographie testing in bronchiolitis. This recommendation allows for greater eonvenienee in managing this eondition in the primary eare office. Chest radiography, considered by many to be a staple in the diagnosis of bronchiolitis, may influence management yet probably has no effect on outcome. In 1 well-known, randomized study, half of more than 500 young children who met World Health Organization criteria for pneumonia underwent chest x-rays, and the other half did not.'^ The children who had chest radiography performed were more likely to receive antibioties, but there was no actual difference in outcomes between the 2 groups. Other studies also demonstrated limited use of chest x-rays in mild to moderately ill children with bronehiolitis.'" " Another study determined that more than 130 ehest x-rays would have to be performed to identify a single abnormality suggestive of an alternate diagnosis in children with symptoms of bronchiolitis, and those abnormalities were not always agreed on by the physicians reading the films.'* Thus, chest x-rays can be avoided in most cases but stui have a role in the patient who has severe illness or is not following a typical disease course, such as when a pneumothorax is susjjected. It is common for practitioners to get a complete blood count in infants with bronchiolitis, but there is a great degree of variation in this practice among children's hospitals.'"* A review of nearly 2,000 RSV-positive patients demonstrated that the likelihood of serious bacterial infection was independent of the level of white blood cell count, which ranged from 5,000 to 30,000/mml- Respiratory infection because of adenovirus specifically has been associated with very significant leukocytosis.^' Changes in recommendations for management of bronchiolitis The recent history of developments in the management of bronchiolitis is a story of recurrent buildup and disappointment. After initial reports of success, inhaled therapy with albuterol and racemic epinephrine i have been shown to provide only a brief benefit to a -' small percentage of infants with bronchiolitis."^- The AAP agrees that clinicians may initiate a trial of bronchodilators but should continue their use only if it results in objective improvement of the patient's condition." Various studies of eorticosteroids have shown no benefit in treating bronchiolitis."'^" However, recent trial results showed that a combination of epinephrine and dexamethasone reduced the likelihood of hospitalization for infants with bronchiolitis who were seen in the emergency department (ED; relative risk reduction, 35%)." When controlling for multiple variables, however, the data lost their statistical significance. Eurthermore, the benefit from the epinephrine arose days after administration, which is not consistent with our understanding of the pharmacology of the drug. In the hospital setting, there are interventions that have been found to shorten length of stay (LOS). These largely pertain to changes in how patients are monitored and to institutional changes, not to novel pharmacopoeia. One study argued that the measuring of pulse oximetry in a continuous fashion prolongs hospitalization unnecessarily.'" In addition, hospital adoption of pathways of care and consequential standardization of care has been shown to be effective for reducing unnecessary therapy and for reducing LOS of infants in several studies.'" '* The latter finding is noteworthy given that there still is considerable variation in how bronchiolitis is treated. This variation of care has been shown to be ineffective and costly.'" In 1 study, more than half of patients received antibiotics, which obviously are of no benefit in a viral syndrome and may have unwanted side effects.^' ContemporaryPediatrics.com FEBRUARY CONTEMPORARY PEDIATRICS 31
3 ^ ^ 3 AAP recommendations for the management of bronchiolitis Assessment Risk factors for severe disease - Age <12 weeks - Cardiopulmonary disease - Immunodeficiency - History of prematurity Hydration and ability to drink fluids Complementary and alternative medical therapies employed by families Do not routinely order labs ^ Do not routinely order radiography J^ÍH Management Administer oxygen if pulse oximetry falls below 90% in previously healthy infants - Continuous pulse oximetry measurement is not necessary once the clinical course improves - Close observation of infants with hemodynamically significant cardiopulmonary disease and premature infants is required A trial of bronchodilators may be indicated; however, continue use only in event of documented clinical response Do not use antibiotics unless there is indication of coexistent bacterial infection Do not routinely use corticosteroids Do not routinely use ribavirin Do not routinely use chest physiotherapy Prevention Palivizumab is indicated in children with prematurity, chronic lung disease, or congenital heart disease Hands should be decontaminated before and after seeing patients - Alcohol-based rubs are preferred - Families should be educated about alcoholbased rubs Avoid passive-smoke exposure Promote breastfeeding Information from American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiotitis.'^ Few evidence-based therapies are available for treatment of bronchiolitis. Management recommendations from the AAP largely are treatments to avoid, including antibiotics, corticosteroids, ribavirin, and routine chest physiotherapy (Table I)." The only treatments recommended include oxygen (if pulse oximetry is <90%) and bronchodilators (with continuation only if the patient shows response). In the absence of available therapies with proven efficacy, desperation among parents and providers alike often leads to use of therapies that have been shown to be less than helpful. Thus, there is a great need for new treatments for bronchiolitis, and many practitioners now are looking toward hypertonic saline inhalational therapy with cautious optimism. Nebulized hypertonic saline Nebulized hypertonic saline for bronchiolitis was first brought to public attention in It previously had been shown to be effective in patients with cystic fibrosis and nasal sinus diseases. The first study in bronchiolitis showed promise in a small outpatientbased trial.^* Further studies followed (Table 2).'^"' Five studies evaluated regimens consisting of 3% saline either alone or in combination with epinephrine or albuterol in inpatients.""" In these studies, the nebulized hypertonic saline regimens consistently decreased LOS by 0.9 to 1.6 days. Given the conflicting nature of the literature on albuterol and epinephrine in bronchiolitis, the consistency of the recent inpatient studies has generated an understandable excitement among clinicians caring for children admitted with this most common of diagnoses. Some caution is needed, however, in interpreting these results. Limitations of the inpatient studies include small sample sizes (from 41 to 126 patients) and a variety of issues related to study design. For example, in their rather small, randomized, controlled trial, Kuzik and colleagues allowed patients to receive albuterol, racemic epinephrine, and steroids at the decision of the provider.'^ This effectively resulted in several very small groups of patients receiving different therapeutic regimens, thus limiting the power of the study to detect additive differences of therapies. Also, in some of the studies, the overall LOS was far above the average for a typical patient with bronchiolitis in the United States. For example, the Chinese studies demonstrated an improvement in LOS by more than 1 day; however, the mean LOS was far higher than what typically is found in the other studies."-"" In contrast to the inpatient studies, the outpatient and ED studies have emerged with mixed results. A lack of utility was observed in 3 studies in which 3% saline plus either epinephrine or albuterol was given in the ED.''' " A study of 65 outpatients treated with 3% saline plus terbutaline reported reductions in clinical severity scores on days 2 to S."" One explanation for the dichotomy between CONTINUED ON PAGE CONTEMPORARY PEDIATRICS FEBRUARY 2011
4 Efñcacy studies of hypertonic saline in bronchiolitis Study Study type N Preparation compared with 0.9% saline as placebo Results Mandelberg 2003«52 3% saline + epinephrine 1 day decrease in LOS Tal 2006" 41 3% saline + epinephrine 0.9 day decrease in LOS Kuzik 2007" 96 3% saline 0.9 day decrease in LOS Luo2010'' 93 3% saline + albuterol 1.4 day decrease in LOS Luo2010" 126 3% saline 1.6 day decrease in LOS Grewal 2009" ED 46 3% saline + epinephrine No difference after 1 or 2 doses Anil 2010" ED 186 3% saline + albuterol or epinephrine No difference after 120 min Kuzik 2010^' ED 81 3% saline + albuterol No difference after 3 doses AI-Ansari2010*' Observation 187 3% or 5% saline + epinephrine Improved clinical severity scores for 5% saline group at 48 h Sarrell 2002"' Outpatient 65 3% saline + terbutaline Improved clinical severity scores on days 2 to 5 Abbreviations: ED, emergency department; LOS, length of stay. CONTINUED EROM PAGE 32 inpatient and outpatient studies of hypertonie saline may be that the medieation needs to be delivered eonsistently over a long time period or at a higher total dosage before a treatment effeet is seen. The 1 positive outpatient study followed patients over 5 days and delivered the drug every 8 hours throughout the study period.'" In eontrast, the 3 negative ED studies delivered the drug for between 1 and 3 doses and followed patients for 2 hours or less.'"' One study, during whieh 3% or 5% saline plus epinephrine was given to 187 patients in a short-stay observation unit, followed patients for between 24 and 48 hours and delivered the medieation every 4 hours."*" In this study, whieh represents an intermediate between the outpatient and ED studies in terms of treatment administration and follow-up, the investigators found signifieant reductions in clinical severity scores for the 5% saline group after 48 hours, but there was no difference in the average LOS in the unit. Currently, there are multiple studies under way further evaluating the efficacy of hypertonic saline. One large study, based in California, will recruit 700 patients and address key issues about whether the therapy is effective, even in the setting of the ED or short LOS."*^ Another study is being performed in the ED,"" and a study from Chile is assessing hypertonic saline as a diluent for albuterol in the outpatient setting.'''' No outpatient studies currently are planned in the United States, although they clearly are needed. Mechanism of action Although the mechanism of action of hypertonie saline in viral bronehiolitis remains to be fully explained, reeent advances in our understanding of the physiology of the airway surface have led to a more complete theory of why it may work. Cilia from airway epithelial cells extend into a periciliary liquid that is coated with an outer mucus layer.''^ The periciliary liquid and mucus layer are known together as the airway surface liquid. The airway surface liquid also contains antibacterial agents, migratory immune system cells, and signaling molecules that help proteet against pulmonary infeetions. Reeent evidence suggests that epithelial cell ion transporters keep the periciliary liquid layer at the optimal height for ciliary beating. In normal airways, cilia beat at a height just at the interface between the periciliary liquid and the mucus layer, and mucus transport is facilitated when mueus heights are maximized. In laboratory models of the airway surfaee epithelium, hypertonic saline solutions increase the height of the airway surfaee liquid and improve mucus transport.'""'^ In healthy volunteers, mueoeiliary transport is improved by nebulized hypertonie saline as well, even producing supranormal rates of mueoeiliary elearanee."* Current understanding of the pathophysiology of viral bronchiolitis comes from autopsy studies and animal models. Viral infection of the bronchiolar epithelium usually is accompanied by a mononuclear infiltrate and submucosal edema. This is followed by epithelial cell 34 CONTEMPORARY PEDIATRICS FEBRUARY 2011
5 FIGURE Proposed mechanism for hypertonic saline efficacy in bronchiolitis. (A) A normal bronchiole. Cilia effectively sweep through airway surface liquid, allowing effective clearance of debris in airway. (B) An infected bronchiole. Dehydration of airway surface liquid causes ineffective ciliary motility. This results in accumulation of debris such as deceased cells and mucous in airway, which causes plugging, atelectasis, and the need for increased work of breathing. (C) A bronchiole treated with hypertonic saline. Osmotic force from 3% normal saline causes influx of water, replenishing the airway surface liquid and allowing for effective clearance of the airway. necrosis, cellular sloughing, and small-airway plugging. Mucociliary clearance is presumed to be decreased. Recently, it has been proposed that dehydration of the airway surface hquid is part of the pathophysiology of viral bronchiolitis.*' In light of new knowledge about the physiology of the airway surface liquid, this hypothesis would account for the apparent clinical utility of hypertonic saline. In other words, hypertonic saline may réhydrate the airway surface liquid and restore normal ciliary function (Figure). There are other proposed mechanisms of action for hypertonic saline in viral bronchiolitis, most of which rely on extrapolation from its highly successful use in cystic fibrosis. For example, in cystic fibrosis, hypertonic saline has been shown to stimulate cough as well as reduce mucus viscosity and improve elasticity in vitro.''^'^" These effects may be because of the breaking of ionic bonds and disruption of crosslinking in the mucus layer.*'* Other investigators have proposed a conformational change in the mucus molecule induced by hypertonic saline.-'' Ciliary beat frequency also may be increased by cytokines induced by hypertonic saline.''- Hypertonic saline is clinically established as promoting productive cough, and it already is used effectively for sputum induction in both normal persons and in asthmatic and cystic fibrosis patients.'^" Safety Theoretical concerns about the safety of hypertonic saline have been raised because it has been used in asthma studies to induce bronchospasm (reversible airway obstruction). Initial studies of hypertonic saline in bronchiolitis paired the medication with bronchodilators in order to prevent bronchospasm. However, it is important to note that asthma studies typically use concentrations of 4.5% saline and deliver much higher nebulized volumes of solution.'' Despite the high concentration and large volume, not all patients with asthma demonstrate bronchospasm. Most of the available studies in bronchiolitis evaluated 3% saline at doses of 2 cc to 4 cc per nebulization, a dose that is much lower in concentration and volume than that used to induce bronchospasm in patients with asthma.'-"'" Also, given that albuterol is not indicated in the majority of bronchiolitis cases, infants with bronchiolitis should not be considered to have the same respiratory physiology as persons with asthma. Safety of hypertonic saline without associated administration of bronchodilators has been assessed in 3 studies. Kuzik and colleagues were the first to investigate the use of 3% saline without directly specifying that it be used concomitantly with a bronchodilator (although bronchodilators were allowed to be prescribed to study participants)." Participants received an average of more than 3 treatments of hypertonic saline alone each day, and there were no reported negative effects on respiratory status. A 0.3% rate of bronchospasm was observed in a retrospective study of 377 doses of 3% saline ContemporaryPedidtrics.com FEBRUARY 2011 CO N TE M P O R A R Y P E D I ATR I C S 35
6 delivered without concomitant bronchodilators. This study addressed only the safety and not the efficacy of the medication.'" In the most recent randomized trial from China, bronchodilators were not administered to any of the study participants.^'' The investigators delivered doses of hypertonic saline as frequently as every 2 hours to more than 100 study participants without reporting any episodes of bronchospasm or significant adverse events. How we might use this therapy Many children's hospitals already have incorporated use of nebulized hypertonic saline into their standard treatment protocols. During the 2010 annual Pédiatrie Hospital Medicine meeting, an informal poll revealed that about a third of pédiatrie hospitalists have moved forward and are routinely using hypertonic saline for bronchiolitis patients. If it proves effective, outpatient applications clearly are next up for study. It may be best, however, for hospitals to refrain from introducing this therapy to await the results of future trials before we further muddy the waters of bronchiolitis management with another potentially ineffective therapy. Once something has been introduced, it can be difficult to curtail its use. In hospital-based pediatrics, there is a history of clinging to ineffective therapy far beyond the point at which it has been demonstrated ineffective. Furthermore, the optimal dosing scheme for nebulized hypertonic saline has yet to be established. Early evidence suggests that routine and relatively frequent use for a prolonged period is likely to be most effective. In the outpatient realm, 3 times per day for 5 days seemed to reduce severity of symptoms."' No other outpatient regimens have been reported in the literature. As of yet, no company has marketed convenient outpatient systems for administration of hypertonic saline in home nebulizer machines. In the inpatient setting, administration schedules have not been consistent. Three studies administered nebulized hypertonic saline every 8 hours until discharge."'"'' In 2 others, hypertonic saline was dosed every 2 hours for 3 doses, every 4 hours for 5 doses, and then every 6 hours until discharge.'"'' Hope for the future It has been frustrating that the diagnostic modalities and therapies commonly employed for bronchiolitis have not been demonstrated to be effective. Lab testing and radiography add benefit only in unusual or severe cases. Corticosteroids and inhalational albuterol and epinephrine are ineffective in most cases. The common use and toxicity of over-the-counter preparations for infants with upper respiratory infections is well described."'^' Hypertonic saline may be beneficial and likely is less toxic than many of the over-the-counter preparations designed for children with viral respiratory illness. Hypertonic saline is already being employed in many health centers around the country. Time v«ll tell whether this promising new therapy deserves a solid foothold in the treatment of bronchiolitis and also how to optimize its delivery. If its efficacy is confirmed, it will be the first routine therapy that shows benefit for these patients. 33 REFERENCES 1. Houben ML, Bont L, Wilbrink B, et al. Clinical prediction rule for RSV bronchiolitis in bealtby newborns: prognostic birth cobort study. Pediatrics, 2011;127(l): Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006;118(6): Shay DK, Hoiman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytiai virus-associated deaths among US children, J Infect Dis. 2001;183(l): Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child. 2009;94(2): Antunes H, Rodrigues H, Silva N, et al. Etiology of bronchiolitis in a hospitalized pédiatrie population: prospective multicenter study. J Clin Viral. 2010;48{2): Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. Wfng/J Mecí. 2004;350(5): Kim JO, Hodinka RL. Serious respiratory illness associated with rhinovirus infection in a pédiatrie population. Clin Diagn Virol. 1998;10(l); Franz A, Adams 0, Willems R, et al Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Gin Virol. 2010;48(4): Gerna G, Campanini G, Rognoni V, et al. Correlation of virai load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy. J Clin Viral. 2008;41(l): Bonzel L, Tenenbaum T, Schroten H, Schildgen O, Schweitzer-Krantz S, Adams 0. Frequent detection of viral coinfection in children hospitalized with acute respiratory tract infection using a real-time polymerase chain reaction. Pediatr Infect Dis J. 2008;27(7): Foulongne V, Guyon G, Rodière M, Segondy M. Human metapneumovirus infection in young children hospitalized with respiratory tract disease. Pediatr Infect Dis J. 2006;25(4): Wolf DG, Greenberg D, Kalkstein D, et al. Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children. Pediatr Infect Dis J. 2006;25(4): Caracciolo S, Minini C, Colombrita D, et al. Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologie and clinical features. Peíy;afrínfecfD/Sc/.2008;27(5): American Academy of Pediatrics Subcommittee on Diagnosis CONTiNUED ON PAGE CONTEMPORARY PEDIATRICS FEBRUARY 2011
7 CONTINUED FROM PAGE 36 and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118(4): Swingler GH, Hussey GD, Zwarenstein M. Randomised controiled trial of clinical outcome after chest radiograph in ambulatory acute lowerrespiratory infection in children. Lancet. 1998;351(9100): Yong JH, Schuh S, Rashidi R, et al. A cost effectiveness analysis of omitting radiography in diagnosis of acute bronchiolitis. Pediatr Pulmonol. 2009;44(2): Luginbuhl LM, Newman TB, Panteli RH, Finch SA, Wasserman RC. Office-based treatment and outcomes for febrile infants with clinically diagnosed bronchioiitis. Pediatrics. 2008;122(5): Schuh S, Lalani A, Ailen U, et al. Evaluation of the utility of radiography in acute bronchiolitis. JPed/air. 2007;150{4): Tarini BA, Garrison MM, Christakis DA. Institutional variation in ordering complete blood counts for children hospitalized with bronchioiitis. JHosp Med. 2007;2{2): Purcell K, Fergie J. Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus iower respiratory tract infection. Pediatr Infect Dis J. 2007;26{4): Peltola V, Mertsola J, Ruuskanen 0. Comparison of total white blood cell count and serum C-reactive protein levels in confirmed bacterial and virai infections. JPecf/afr. 2006;149(5): Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2010;(12):CD Corneli HM, Zorc JJ, Mahajan P, et al. A muiticenter, randomized, controlled trial of dexamethasone for bronchiolitis. «EngI J Med. 2007;357(4): Fernandes RM, Bialy LM, Vandermeer B, et al Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2010;(10):CD Plint AC, Johnson DW, Patel H, et al. Epinephrine and dexamethasone in children with bronchiolitis. Ai EngI J Med. 2009;360(20); Schroeder AR, Marmor AK, Panteli RH, Newman TB. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2004;158(6): Kotagal UR, Robbins JM, Kini NM, Schoettker PJ, Atherton HD, Kirschbaum MS. Impact of a bronchiolitis guideline: a multisite demonstration project. Chest. 2002;121(6): Perlstein PH, Kotagal UR, Boiling C, et al. Evaluation of an evidencebased guideline for bronchiolitis. Pediatrics. 1999;104(6): Muething S, Schoettker PJ, Gerhardt WE, Atherton HD, Britto MT, Kotagal UR. Decreasing overuse of therapies in the treatment of bronchiolitis by incorporating evidence at the point of care. J Pediatr. 2004;144(6): Willson DF, Horn SD, Hendley JO, Smout R, Gassaway J. Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatrics. 2001;108(4): Knapp JF, Simon SD, Sharma V. Quality of care for common pédiatrie respiratory illnesses in United States emergency departments: analysis of 2005 National Hospital Ambulatory Medicai Care Survey Data. Pediatrics. 2008;122(6): Mandelberg A, Tai G, Witzling M, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest. 2003;123(2): Tal G, Cesar K, Oron A, Houri S, Baliin A, Mandeiberg A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med»ssoc J.2006;8(3): Kuzik BA, AI Qadhi SA, Kent S, et al. Nebulized hypertonic saline in the treatment of viral bronchiolihs in infants. J Pediatr 2007;151(3): ,27O.el. 35. Luo Z, Liu E, Luo J, Li S, et al. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int. 2010;52(2): Luo Z, Fu Z, Liu E, et al. A randomized controlled trial of nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchioiitis. Gin MicrobioiInfect Epub ahead of print. 37. Grewal S, Ali S, McConneii DW, Vandermeer B, Klassen TP. A randomized triai of nebulized 350 hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med. 2009;163(ll): Anil AB, Anii M, Saglam AB, Cetin N, Bal A, Aksu N. High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normai saline, and 3% saline in mild bronchiolitis. Pediatr Pulmonol. 2010;45(l): Kuzik BA, Flavin MP, Kent S, et al. Effect of inhaled hypertonic saline on hospital admission rate in children with viral bronchiolitis: a randomized trial. CJEM. 2010;12(6): Al-Ansari K, Sakran M, Davidson BL, El Sayyed R, Mahjoub H, Ibrahim K. Nebulized 550 or 350 hypertonic or 0.9' í) saline for treating acute bronchiolitis in infants. JPed/afr. 2010;157(4): ,634.el. 41. Sarrell EM, Tal G, Witzling M, et al. Nebulized 39!) hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest. 2002;122(6): US Nationai Institutes of Health. Nebulized hypertonic saline for bronchiolitis. ClinicalTrials.gov Web site, NCTD ?term=hypertonic+saline+AND+bronchiolitis&rank=7. Accessed January 12, US National Institutes of Health. Hypertonic saline for acute bronchiolitis. ClinicalTrials.gov Web site, NCT ?term=hypertonic+saline+AND+bronchiolitis&rank=4. Accessed January 12, US National Institutes of Health. Hypertonic salme for outpatient bronchiolitis. ClinicalTrials.gov Web site, NCT ?term=hypertonic-l-saline-l-AND+bronchiolitis&rank=8. Accessed January 12, Tarran R. Regulation of airway surface liquid volume and mucus transport by active ion transport. Proc Am Thorac Soc. 2004;l(l): Tarran R, Grubb BR, Parsons D, et al. Tbe CF salt controversy: in vivo observations and therapeutic approaches. Mol Celt. 2001;8(l): Wills PJ, Hall RL, Chan W, Cole PJ. Sodium chloride increases the ciliary transportability of cytic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest. 1997;99(1): Sood N, Bennett WD, Zeman K, et al. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects. Am J Respir Crit Care Med 2003;167(2): Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Puimonoi. 2010;45(l): Elkins MR, Bye PT. Inhaled hypertonic saline as a therapy for cystic fibrosis. Curr Opin Pulm Med 2006;12{6): Lieberman J. Inhibition of protease activity in purulent sputum by DNA. J Lab Clin Med. 1967;70(4): Wabnitz DA, Wormald PJ. A blinded, randomized, controlled study on the effect of buffered 0.95Ó and 35'i sodium chloride intranasal sprays on ciliary beat frequency. Laryngoscope. 2005;115(5): Anderson SD. Indirect challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2 suppl):25s-30s. 54. Ralston S, Hill V, Martinez M. Nebulized hypertonic saline without adjunctive bronchodilators for children with bronchiolitis. Pediatrics. 2010;126(3):e520-e Rimsza ME, Newberry S. Unexpected infant deaths associated with use of cough and cold medications. Pediatrics. 2008;122(2):e318-e Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Cough and cold medication use by US children, : results from the slone survey. Pediatrics. 2008;122(2):e323-e CONTEMPORARY PEDIATRICS FEBRUARY 2011
8 Copyright of Contemporary Pediatrics is the property of Advanstar Communications Inc. and its content may not be copied or ed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or articles for individual use.
Early Studies. Then, the Meta-analysis. Recent Studies Al-Ansari. Recent Studies Luo University of Texas Health Science Center at San Antonio
Pediatrics Grand Rounds Objectives Review the available literature on the use of nebulized hypertonic saline in the treatment of acute viral bronchiolitis Review proposed mechanism(s) of action and safety
More informationNebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis
ORIGINAL ARTICLE INFECTIOUS DISEASES Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng, Y. Liu, S.
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Bronchiolitis: diagnosis and management of bronchiolitis in children. 1.1 Short title Bronchiolitis in children 2 The remit The
More informationBronchiolitis & Hypertonic Saline
Bronchiolitis & Hypertonic Saline Andrea Scheid MD FAAP Director, Pediatric Hospitalist Service & Medical Unit Director, Pediatric Floor Beaumont Children s Hospital, Royal Oak Assistant Professor, Oakland
More informationPediatric Bronchiolitis. Janie Robles, PharmD, AE-C Assistant Professor of Pharmacy Practice Pediatrics School of Pharmacy TTUHSC Lubbock, Texas
This PowerPoint file is a supplement to the video presentation. Some of the educational content of this program is not available solely through the PowerPoint file. Participants should use all materials
More informationNebulized Hypertonic Saline for Bronchiolitis in the Emergency Department A Randomized Clinical Trial
Research Original Investigation in the Emergency Department A Randomized Clinical Trial Todd A. Florin, MD, MSCE; Kathy N. Shaw, MD, MSCE; Marlena Kittick, MPH; Stephen Yakscoe, BA; Joseph J. Zorc, MD,
More informationManagement of Bronchiolitis: A Clinical Update
Prepared for your next patient. TM Management of Bronchiolitis: A Clinical Update Todd A. Florin, MD, MSCE, FAAP Assistant Professor, Department of Pediatrics University of Cincinnati College of Medicine
More informationA Comparative Study on Use of 3% Saline Versus 0.9% Saline Nebulization in Children with Bronchiolitis
J Nepal Health Res Counc 2014 Jan;12(26):39-43 Original Article A Comparative Study on Use of 3% Saline Versus 0.9% Saline Nebulization in Children with Bronchiolitis Ojha AR, 1 Mathema S, 1 Sah S, 1 Aryal
More informationClinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
Guidance for the Clinician in Rendering Pediatric Care CLINICAL PRACTICE GUIDELINE Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis abstract This guideline is a revision
More informationURIs and Pneumonia. Elena Bissell, MD 10/16/2013
URIs and Pneumonia Elena Bissell, MD 10/16/2013 Objectives Recognize and treat community acquired PNA in children/adults Discern between inpatient and outpatient treatment of PNA Recognize special populations/cases
More informationBRONCHIOLITIS. Introduction
BRONCHIOLITIS Introduction Bronchiolitis is the most common lower respiratory infection in infants and a leading cause of hospital admission in this age group. It is a viral infection and is most commonly
More informationVideo Cases in Pediatrics. Ran Goldman, MD BC Children s Hospital University of British
Video Cases in Pediatrics Ran Goldman, MD BC Children s Hospital University of British Columbia @Dr_R_Goldman Bronchiolitis Viral infection of the lower respiratory tract characterized by acute inflammation,
More informationNebulized Hypertonic-Saline vs Epinephrine for Bronchiolitis: Proof of Concept Study of Cumulative Sum (CUSUM) Analysis
R E S E A R C H P A P E R Nebulized Hypertonic-Saline vs Epinephrine for Bronchiolitis: Proof of Concept Study of Cumulative Sum (CUSUM) Analysis NEERAJ GUPTA, *ASHISH PULIYEL, AYUSH MANCHANDA AND JACOB
More informationUtility of Hypertonic Saline in the Management of Acute Bronchiolitis in Infants: A Randomised Controlled Study
Original Article Elmer Press Utility of Hypertonic Saline in the Management of Acute Bronchiolitis in Infants: A Randomised Controlled Study Sadbhavna Pandit a, Neeraj Dhawan a, b, Deepak Thakur a, b Abstract
More informationCYSTIC FIBROSIS FOUNDATION INFO-POD Information You Need to Make Benefits Decisions
CYSTIC FIBROSIS FOUNDATION INFO-POD Information You Need to Make Benefits Decisions Issue 1: Hypertonic Saline Summary: Preserving lung function is a crucial element in the care of the individual with
More informationSeminar. Viral bronchiolitis
Viral bronchiolitis Todd A Florin, Amy C Plint, Joseph J Zorc Viral bronchiolitis is a common clinical syndrome affecting infants and young children. Concern about its associated morbidity and cost has
More informationManagement of bronchiolitis
Management of bronchiolitis Madeleine Adams Iolo Doull Abstract Bronchiolitis is the commonest cause of hospital admission in infancy. Severity varies from mild and self-limiting through to respiratory
More informationDiagnosis and Management of Bronchiolitis
CLINICAL PRACTICE GUIDELINE Diagnosis and Management of Bronchiolitis Organizational Principles to Guide and Define the Child Health Care System and/or Improve the Health of All Children Subcommittee on
More informationApproach to Bronchiolitis
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Approach to Bronchiolitis. These podcasts are designed to give medical students an overview of key topics in pediatrics.
More informationBronchiolitis Management Before and After the AAP Guidelines
ARTICLE Bronchiolitis Management Before and After the AAP Guidelines AUTHORS: Kavita Parikh, MD, a Matthew Hall, PhD, b and Stephen J. Teach, MD, MPH c a Division of Hospitalist Medicine, and c Division
More informationNebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial
Khanal et al. BMC Pediatrics (2015) 15:115 DOI 10.1186/s12887-015-0434-4 RESEARCH ARTICLE Open Access Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double
More informationPediatric Respiratory Disease: A Model for the Future of Emergency Medicine Research
Pediatric Respiratory Disease: A Model for the Future of Emergency Medicine Research Joseph J. Zorc, MD, MSCE Mark Fishman Professor, Department of Pediatrics Perelman School of Medicine, University of
More informationTREAMENT OF RECURRENT VIRUS-INDUCED WHEEZING IN YOUNG CHILDREN. Dr Lại Lê Hưng Respiratory Department
TREAMENT OF RECURRENT VIRUS-INDUCED WHEEZING IN YOUNG CHILDREN Dr Lại Lê Hưng Respiratory Department Literature review current through: Feb 2013. This topic last updated: Aug 14, 2012 INTRODUCTION Wheezing
More informationRespiratory Scores as a Tool to Reduce Bronchodilator Use in Children Hospitalized With Acute Viral Bronchiolitis
RESEARCH ARTICLE Respiratory Scores as a Tool to Reduce Bronchodilator Use in Children Hospitalized With Acute Viral Bronchiolitis Grant M. Mussman, MD, MHSA, a Rashmi D. Sahay, MD, MS, b Lauren Destino,
More informationA Trust Guideline for the Management of. Bronchiolitis in Infants and Children under the age of 24 months
A Clinical Guideline recommended Children s Assessment Unit (CAU), Buxton Ward, For use in: Children s Day Ward, Jenny Lind Out-patients Department, Accident and Emergency Department By: Medical and Nursing
More informationNebulized Hypertonic Saline for Treating Bronchiolitis in Infants A Randomised Clinical Trial Conducted In Tertiary Care Teaching Hospital
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 4 Ver. X (Apr. 2016), PP 99-105 www.iosrjournals.org Nebulized Hypertonic Saline for Treating
More informationSIB Chart Review Tool
SIB Chart Review Tool Month/Year Chart Number (number sequentially 1-20) The first three questions are the same for BOTH the Inpatient and ED chart review tools. Inclusion Criteria Exclusion Criteria Age
More informationBronchiolitis: when to reassure and monitor, and when to refer
CHILD health Respiratory conditions Bronchiolitis: when to reassure and monitor, and when to refer Key practice points: Bronchiolitis should be diagnosed clinically; blood tests, analysis of sputum, testing
More informationBronchiolitis is the leading cause of infant hospitalization
ORIGINAL ARTICLE Bronchiolitis Clinical Characteristics Associated With Hospitalization and Length of Stay Howard M. Corneli, MD,* Joseph J. Zorc, MD,Þ Richard Holubkov, PhD,þ Joan S. Bregstein, MD, Kathleen
More informationWheezy? Easy Peasy! The Emergent Management of Asthma & Bronchiolitis. Maneesha Agarwal MD Assistant Professor of Pediatrics & Emergency Medicine
Wheezy? Easy Peasy! The Emergent Management of Asthma & Bronchiolitis Maneesha Agarwal MD Assistant Professor of Pediatrics & Emergency Medicine Asthma Defined National Asthma Education and Prevention
More informationNational Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008
Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis April 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not
More informationThe Link Between Viruses and Asthma
The Link Between Viruses and Asthma CATHERINE KIER, MD Professor of Clinical Pediatrics Division Chief, Pediatric Pulmonary, and Cystic Fibrosis Center Director, Pediatric Sleep Disorders Center SUNY Stony
More informationDiscuss the benefits for developing an outpatient bronchiolitis clinic.
Diana L Mark, RRT Pediatric Clinical Specialist Respiratory Care Wesley Medical Center Discuss the benefits for developing an outpatient bronchiolitis clinic. 1 Definition Inflammation of the bronchioles
More informationWheeze. Respiratory Tract Symptoms. Prof RJ Green Department of Paediatrics. Cough. Wheeze/noisy breathing. Acute. Tight chest. Shortness of breath
Wheeze Prof RJ Green Department of Paediatrics Respiratory Tract Symptoms Cough Tight chest Wheeze/noisy breathing Shortness of breath Acute Chronic Respiratory rate Most important sign of respiratory
More informationPEDIATRIC RESPIRATORY ILLNESS MADE SIMPLE
Copyright 2012 Joel Berezow, MD and The Pediatrics for Emergency Physicians Network All rights reserved. Duplication in whole or in part, or electronic transmission in any form, is prohibited THE PEDIATRICS
More informationManagement of Common Respiratory Disorders in Children. Whitney Pressler, MD Pediatric Brown Bag Series Webinar June 14, 2016
Management of Common Respiratory Disorders in Children Whitney Pressler, MD Pediatric Brown Bag Series Webinar June 14, 2016 Disclosures I have no financial relationships to disclose I will not be discussing
More informationManagement of Common Respiratory Disorders in Children. Disclosures. Roadmap 6/10/2016
Management of Common Respiratory Disorders in Children Whitney Pressler, MD Pediatric Brown Bag Series Webinar June 14, 2016 Disclosures I have no financial relationships to disclose I will not be discussing
More informationCYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE
CYSTIC FIBROSIS Madhu Pendurthi MD MPH Staff Physician, Mercy Hospital Springfield, MO NO CONFLICT OF INTEREST TO DISCLOSE OBJECTIVES Epidemiology of Cystic Fibrosis (CF) Genetic basis and pathophysiology
More informationNebulized Hypertonic Saline for Acute Bronchiolitis: A Systematic Review
Nebulized Hypertonic Saline for Acute Bronchiolitis: A Systematic Review Linjie Zhang, MD, PhD a, Raúl A. Mendoza-Sassi, MD, PhD a, Terry P. Klassen, MD b, Claire Wainwright, MD c BACKGROUND AND OBJECTIVE:
More informationan inflammation of the bronchial tubes
BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious
More informationAerosol Therapy. Aerosol Therapy. RSPT 1410 Humidity & Aerosol Therapy Part 4
1 RSPT 1410 Humidity & Part 4 Wilkins Chapter 36; p. 801-806 2 Stability: the tendency for aerosol particles to remain in Size: the the particle, the greater the tendency toward stability the the particle,
More informationBronchiolitis v.2.0: Criteria and Respiratory Score
Bronchiolitis v.2.0: Criteria and Respiratory Score Executive Summary Test your knowledge Epidemiology, Pathophysiology & Natural History Inclusion Criteria Age
More informationCOPD exacerbation. Dr. med. Frank Rassouli
Definition according to GOLD report: - «An acute event - characterized by a worsening of the patients respiratory symptoms - that is beyond normal day-to-day variations - and leads to a change in medication»
More informationBRONCHIOLITIS. See also the PSNZ guideline - Wheeze & Chest Infections in infants under 1 year (www.paediatrics.org.nz)
Definition What is Bronchiolitis? Assessment Management Flow Chart Admission Guidelines Investigations Management Use of Bronchodilators Other treatments Discharge Planning Bronchiolitis & Asthma References
More informationManagement of Bronchiolitis in Infants
Co-issued by Paediatric Medicine and the Division of Paediatric Emergency Medicine. 1.0 Introduction Bronchiolitis is an acute inflammatory disease of the lower respiratory tract, resulting from obstruction
More informationBronchiolitis: Recent Evidence on Diagnosis and Management Joseph J. Zorc and Caroline Breese Hall. DOI: /peds
Bronchiolitis: Recent Evidence on Diagnosis and Management Joseph J. Zorc and Caroline Breese Hall Pediatrics published online Jan 25, 2010; DOI: 10.1542/peds.2009-2092 The online version of this article,
More informationBronchiolitis: What s the latest evidence?
Bronchiolitis: What s the latest evidence? Leanne DePalma, MD Division of Hospital Medicine Washington University Department of Pediatrics I have no financial disclosures. 1 Goals and Objectives Goal:
More informationMai ElMallah,MD Updates in Pediatric Pulmonary Care XII: An Interdisciplinary Program April 13, 2012
Mai ElMallah,MD Updates in Pediatric Pulmonary Care XII: An Interdisciplinary Program April 13, 2012 Recognize the importance of Pulmonary Function Testing in Cystic Fibrosis Be aware of different types
More informationRunning head: COMMON COLD AND BRONCHITIS 1
Running head: COMMON COLD AND BRONCHITIS 1 Common Cold and Bronchitis Name: Institution: COMMON COLD AND BRONCHITIS 2 Common Cold and Bronchitis Bronchitis also labeled in medical terminology as acute
More informationElliott J. Carande, Andrew J. Pollard, and Simon B. Drysdale
Canadian Infectious Diseases and Medical Microbiology Volume 2016, Article ID 9139537, 5 pages http://dx.doi.org/10.1155/2016/9139537 Research Article Management of Respiratory Syncytial Virus Bronchiolitis:
More informationDr Conroy Wong. Professor Richard Beasley. Dr Sarah Mooney. Professor Innes Asher
Professor Richard Beasley University of Otago Director Medical Research Institute of New Zealand Wellington Dr Sarah Mooney Physiotherapy Advanced Clinician Counties Manukau Health NZ Respiratory and Sleep
More informationObjectives. Case Presentation. Respiratory Emergencies
Respiratory Emergencies Objectives Describe how to assess airway and breathing, including interpreting information from the PAT and ABCDEs. Differentiate between respiratory distress, respiratory failure,
More informationUniversity of Groningen. Exercise induced bronchoconstriction in childhood asthma van Leeuwen, Janneke
University of Groningen Exercise induced bronchoconstriction in childhood asthma van Leeuwen, Janneke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to
More informationClinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)
Clinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Reference: NHS England: 16029/P NHS England INFORMATION READER BOX Directorate Medical Operations and
More informationUpper Respiratory Tract Infections
Upper Respiratory Tract Infections OTITIS MEDIA Otitis media is an inflammation of the middle ear. There are more than 709 million cases of otitis media worldwide each year; half of these cases occur in
More informationPAEDIATRIC RESPIRATORY FAILURE. Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre
PAEDIATRIC RESPIRATORY FAILURE Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre Outline of lecture Bronchiolitis Bronchopulmonary dysplasia Asthma ARDS Bronchiolitis
More informationThe ABCs of. By Christine I. Krause, DNP, APRN, FNP-BC, PNP-BC
The ABCs of Abstract: Respiratory syncytial virus (RSV) is a common viral infection affecting many children in the United States. This seasonal virus is the leading cause of hospitalization of infants
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXX NUMBER 1 January 2015 CONTAGIOUS COMMENTS Department of Epidemiology Respiratory Season 2014 15 Kellie Rusin MLS (ASCP)CM MPH, Christine Robinson PhD, James Gaensbauer MD, MScPH, & the Respiratory
More informationEstimating RSV Disease Burden in the United States
Estimating RSV Disease Burden in the United States Brian Rha, MD, MSPH Medical Epidemiologist, Division of Viral Diseases Centers for Disease Control and Prevention Severe Acute Respiratory Infection Surveillance
More informationAnnamalai Nagar, Tamil Nadu India. Corresponding Author: Riya Teresa Joseph
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 12, Issue 4 Ver. IV (Jul Aug 2017), PP 01-07 www.iosrjournals.org Study of Nebulization with Hypertonic
More informationNormal Saline vs. Hypertonic Saline Nebulization for Acute Bronchiolitis: A Randomized Clinical Trial
http:// ijp.mums.ac.ir Original Article (Pages: 8507-8516) Normal Saline vs. Hypertonic Saline Nebulization for Acute Bronchiolitis: A Randomized Clinical Trial Mohsen Reisi 1, Narges Afkande 2, Hasan
More informationManagement of wheeze in pre-school children. Prof Colin Robertson, Respiratory Medicine, Royal Children s Hospital, Melbourne
Management of wheeze in pre-school children Prof Colin Robertson, Respiratory Medicine, Royal Children s Hospital, Melbourne General Practitioner encounters for asthma Asthma in Australia, 2003 Emergency
More informationEpiglottitis. Bronchitis. Bronchiolitis. Pneumonia. Croup syndrome. Miss. kamlah 2
Miss. kamlah 1 Epiglottitis. Bronchitis. Bronchiolitis. Pneumonia. Croup syndrome. Miss. kamlah 2 Acute Epiglottitis Is an infection of the epiglottis, the long narrow structure that closes off the glottis
More informationUpdate on Rhinosinusitis 2013 AAP Guidelines Review
Update on Rhinosinusitis 2013 AAP Guidelines Review Carla M. Giannoni, MD Surgeon, Otolaryngology Texas Children's Hospital Professor, Surgery and Pediatrics, Baylor College of Medicine CDC: Acute Rhinosinusitis
More informationFacilitator s Guide. Prescription Writing/Patient Safety Author: Benjamin Estrada, MD, University of South Alabama. Active Learning Module
Facilitator s Guide Prescription Writing/Patient Safety Author: Benjamin Estrada, MD, University of South Alabama Active Learning Module Core Concepts In order to master this topic area, students must
More informationChapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews
Chapter 10 Respiratory System J00-J99 Presented by: Jesicca Andrews 1 Respiratory System 2 Respiratory Infections A respiratory infection cannot be assumed from a laboratory report alone; physician concurrence
More informationA Place For Airway Clearance Therapy In Today s Healthcare Environment
A Place For Airway Clearance Therapy In Today s Healthcare Environment Michigan Society for Respiratory Care 2015 Fall Conference K. James Ehlen, MD October 6, 2015 Objectives Describe patients who will
More informationPNEUMONIA IN CHILDREN. IAP UG Teaching slides
PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children
More informationQuick Literature Searches
Quick Literature Searches National Pediatric Nighttime Curriculum Written by Leticia Shanley, MD, FAAP Institution: University of Texas Southwestern Medical Center Case 1 It s 1:00am and you have just
More informationShared Care Guideline
Shared Care Guideline Gentamicin for Nebulisation For the long term prophylaxis of chronic lung infections in non CF bronchiectasis Executive Summary Indication Nebulised gentamicin is indicated in patients
More informationARTICLE. Suctioning and Length of Stay in Infants Hospitalized With Bronchiolitis
ARTICLE Suctioning and Length of Stay in Infants Hospitalized With Bronchiolitis Grant M. Mussman, MD; Michelle W. Parker, MD; Angela Statile, MD; Heidi Sucharew, PhD; Patrick W. Brady, MD, MSc Importance:
More informationRelevant Papers: eight relevant articles were found, but four were reviewed because they were most directly related to the topic
Topic: Prehospital use of bromide paired with salbutamol as treatment for shortness of breath. Author: Lisa Henderson Clinical Scenario: Two primary care paramedics respond code 4 for a 55 year old male
More informationRespiratory Syncytial Virus (RSV) in Older Adults: A Hidden Annual Epidemic. Webinar Agenda
Respiratory Syncytial Virus (RSV) in Older Adults: A Hidden Annual Epidemic Wednesday, November 2, 2016 12:00 PM ET Webinar Agenda Agenda Welcome and Introductions William Schaffner, MD, NFID Medical Director
More informationRSV Bronchiolitis in Children The Bird s Eye View
RSV Bronchiolitis in Children The Bird s Eye View Nidal El-wiher, M.D. & Steve Lauer PhD MD Department of Pediatrics University of Kansas Medical Center April 19 th 2012 Case 10 mo male admitted to PICU
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationThe University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Pulmonary
The University of Arizona Pediatric Residency Program Primary Goals for Rotation Pulmonary 1. GOAL: Diagnose and manage patients with asthma. 2. GOAL: Understand the role of the pediatrician in preventing
More informationEvaluation of Patients with Diffuse Bronchiectasis
Evaluation of Patients with Diffuse Bronchiectasis Dr. Patricia Eshaghian, MD Assistant Clinical Professor of Medicine Director, UCLA Adult Cystic Fibrosis Affiliate Program UCLA Division of Pulmonary
More informationRunning Head: THE PRACTICALITY OF BRONCHIAL THERMOPLASTY 1. Review of a New Treatment for Severe Asthma: The Practicality of Bronchial Thermoplasty
Running Head: THE PRACTICALITY OF BRONCHIAL THERMOPLASTY 1 Review of a New Treatment for Severe Asthma: The Practicality of Bronchial Thermoplasty Jessica Orpen Northeastern University THE PRACTICALITY
More informationAssessing wheeze in pre-school children
Assessing wheeze in pre-school children 8 Wheeze in children aged less than five years has many potential causes. Often it is regarded as the first sign of asthma, however, a substantial proportion of
More informationChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease By: Dr. Fatima Makee AL-Hakak () University of kerbala College of nursing Out lines What is the? Overview Causes of Symptoms of What's the difference between and asthma?
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationPIDS AND RESPIRATORY DISORDERS
PRIMARY IMMUNODEFICIENCIES PIDS AND RESPIRATORY DISORDERS PIDS AND RESPIRATORY DISORDERS 1 PRIMARY IMMUNODEFICIENCIES ABBREVIATIONS COPD CT MRI IG PID Chronic obstructive pulmonary disease Computed tomography
More information4.6 Small airways disease
4.6 Small airways disease Author: Jean-Marc Fellrath 1. INTRODUCTION Small airways are defined as any non alveolated and noncartilaginous airway that has an internal diameter of 2 mm. Several observations
More informationEarly Halt of a Randomized Controlled Study with 3% Hypertonic Saline in Acute Bronchiolitis
Clinical Investigations Received: October 6, 2016 Accepted after revision: May 14, 2017 Published online: June 24, 2017 Early Halt of a Randomized Controlled Study with 3% Hypertonic Saline in Acute Bronchiolitis
More informationBronchiolitis Update. Key reviewer: Dr Philip Pattemore, Associate Professor of Paediatrics, University of Otago, Christchurch.
www.bpac.org.nz keyword: bronchiolitis Bronchiolitis Update Key reviewer: Dr Philip Pattemore, Associate Professor of Paediatrics, University of Otago, Christchurch Key Points: Bronchiolitis is the most
More informationIntegrated Cardiopulmonary Pharmacology Third Edition
Integrated Cardiopulmonary Pharmacology Third Edition Chapter 13 Pharmacologic Management of Asthma, Chronic Bronchitis, and Emphysema Multimedia Directory Slide 7 Slide 12 Slide 60 COPD Video Passive
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationCystic Fibrosis Panel Applications (Dornase Alfa) Contents
Cystic Fibrosis Panel Applications (Dornase Alfa) Contents Page 2-4: Entry and Stopping Criteria for Treatment with Dornase Alfa Page 5-9: Application and consent forms for a one month trail and long term
More informationPAEDIATRIC ACUTE CARE GUIDELINE. Croup. This document should be read in conjunction with this DISCLAIMER
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Croup Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be read in conjunction
More informationBronchiolitis: Systematic Review with 3 Decades of Experience in Resource-limited Setting
Cronicon OPEN ACCESS EC PAEDIATRICS Review Article Bronchiolitis: Systematic Review with 3 Decades of Experience in Resource-limited Setting Suraj Gupte* Professor and Head, Postgraduate Department of
More informationGOALS AND INSTRUCTIONAL OBJECTIVES
October 4-7, 2004 Respiratory GOALS: GOALS AND INSTRUCTIONAL OBJECTIVES By the end of the week, the first quarter student will have an in-depth understanding of the diagnoses listed under Primary Diagnoses
More informationMAYA RAMAGOPAL M.D. DIVISION OF PULMONOLOGY & CYSTIC FIBROSIS CENTER
MAYA RAMAGOPAL M.D. DIVISION OF PULMONOLOGY & CYSTIC FIBROSIS CENTER 16 year old female with h/o moderate persistent asthma presents to the ED after 6 hours of difficulty breathing, cough, and wheezing
More informationRespiratory System Virology
Respiratory System Virology Common Cold: Rhinitis. A benign self limited syndrome caused by several families of viruses. The most frequent acute illness in industrialized world. Mild URT illness involving:
More informationThe effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial
ORIGINAL ARTICLE PAEDIATRIC PULMONOLOGY The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial Jasmijn Teunissen 1, Anne H.J. Hochs 1, Anja Vaessen-Verberne 2,
More informationThe effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial
ERJ Express. Published on July 25, 2014 as doi: 10.1183/09031936.00159613 ORIGINAL ARTICLE IN PRESS CORRECTED PROOF The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled
More informationPediatric Respiratory Infections
Pediatric Respiratory Infections Brenda Kelly PharmD BCPS Residency Program Director Virginia Mason Memorial, Yakima, Washington brendakelly@yvmh.org Disclosure The presenter has no actual or potential
More informationESCMID Online Lecture Library. by author
INFLUENZA IN CHILDREN Cristian Launes Infectious Diseases Unit. Department of Paediatrics. Hospital Sant Joan de Déu (Universitat de Barcelona) Innovation in Severe Acute Respiratory Infections (SARI),
More informationIs There a Treatment for BPD?
Is There a Treatment for BPD? Amir Kugelman, Pediatric Pulmonary Unit and Department of Neonatology Bnai Zion Medical Center, Rappaport Faculty of Medicine Haifa, Israel Conflict of Interest Our study
More informationMCH-Immunization Conference. September 2012
MCH-Immunization Conference September 2012 Rosalyn Singleton MD Arctic Investigations Program-CDC Alaska Native Tribal Health Consortium, Anchorage, AK DISCLAIMER: The results and conclusions presented
More information